Physician profile
Jonathan J Lee
NPI 1982874855
$1,407.66
in general payments reported to CMS, 2019-2025
12 companies · $668 in 2025
The $668 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2021: $122 · 2022: $77.00 · 2024: $430 · 2025: $668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,022 · Travel and Lodging: $75.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,022.15 |
| Travel and Lodging | $75.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $285.63 | 2025 | Prospera |
| Inari Medical, INC. | $181.48 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Globus Medical, INC. | $153.79 | 2025 | Senza |
| Shockwave Medical, INC | $147.65 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $121.84 | 2021 | |
| Abbott Laboratories | $119.87 | 2025 | Proclaim |
| Olympus America INC. | $110.82 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $89.55 | 2025 | |
| Boston Scientific Corporation | $77.00 | 2022 | |
| Medtronic, INC. | $75.85 | 2024 | Intellis Adaptivestim |
| Lemaitre Vascular, INC. | $25.08 | 2024 | Restoreflow |
| Stryker Corporation | $19.10 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.